ATE298241T1 - Behandlung von atemstillstand im schlaf - Google Patents

Behandlung von atemstillstand im schlaf

Info

Publication number
ATE298241T1
ATE298241T1 AT98915618T AT98915618T ATE298241T1 AT E298241 T1 ATE298241 T1 AT E298241T1 AT 98915618 T AT98915618 T AT 98915618T AT 98915618 T AT98915618 T AT 98915618T AT E298241 T1 ATE298241 T1 AT E298241T1
Authority
AT
Austria
Prior art keywords
treatment
during sleep
breakfast
breakfast during
sleep
Prior art date
Application number
AT98915618T
Other languages
English (en)
Inventor
Keith C Meyer
M Safwan Badr
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE298241T1 publication Critical patent/ATE298241T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT98915618T 1997-04-16 1998-04-16 Behandlung von atemstillstand im schlaf ATE298241T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/834,369 US5958902A (en) 1997-04-16 1997-04-16 Method and composition for treating sleep apnea
PCT/US1998/007735 WO1998046245A1 (en) 1997-04-16 1998-04-16 Method and composition for treating sleep apnea

Publications (1)

Publication Number Publication Date
ATE298241T1 true ATE298241T1 (de) 2005-07-15

Family

ID=25266775

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98915618T ATE298241T1 (de) 1997-04-16 1998-04-16 Behandlung von atemstillstand im schlaf

Country Status (24)

Country Link
US (3) US5958902A (de)
EP (1) EP1009411B1 (de)
JP (1) JP2001507364A (de)
KR (1) KR100381643B1 (de)
CN (1) CN1252727A (de)
AR (1) AR012221A1 (de)
AT (1) ATE298241T1 (de)
AU (1) AU722866B2 (de)
BG (1) BG103800A (de)
BR (1) BR9809090A (de)
CA (1) CA2285574C (de)
CO (1) CO4940399A1 (de)
DE (1) DE69830660T2 (de)
HK (1) HK1026141A1 (de)
HU (1) HUP0002645A3 (de)
ID (1) ID29298A (de)
IL (2) IL132133A0 (de)
NO (1) NO994613L (de)
NZ (1) NZ337969A (de)
PL (1) PL336326A1 (de)
SK (1) SK143199A3 (de)
TR (1) TR199902577T2 (de)
TW (1) TWI221771B (de)
WO (1) WO1998046245A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933032B2 (en) 1998-10-20 2015-01-13 Children's Hospital Medical Center Surfactant protein D for the treatment of disorders associated with lung injury
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6514482B1 (en) 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6641542B2 (en) * 2001-04-30 2003-11-04 Medtronic, Inc. Method and apparatus to detect and treat sleep respiratory events
AU2003217544A1 (en) * 2002-02-15 2003-09-09 Cns, Inc. Throat spray
WO2003079992A2 (en) 2002-03-20 2003-10-02 Advanced Inhalation Research, Inc. Pulmonary delivery for levodopa
US7992566B2 (en) 2002-12-30 2011-08-09 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US7647931B2 (en) 2002-12-30 2010-01-19 Quiescence Medical, Inc. Stent for maintaining patency of a body region
WO2007005672A2 (en) * 2005-06-30 2007-01-11 The Scripps Research Institute Treatment and prevention of respiratory diseases and conditions
JP2007190275A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器
JP2007190277A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器および呼吸訓練プログラム
JP2007190278A (ja) 2006-01-20 2007-08-02 Omron Healthcare Co Ltd 呼吸訓練器
WO2007098202A2 (en) 2006-02-16 2007-08-30 Imthera Medical, Inc. An rfid based apparatus, system, and method for therapeutic treatment of a patient
WO2007147046A2 (en) * 2006-06-14 2007-12-21 Zmed Technologies, Inc. Respiration stimulation
US7734350B2 (en) * 2006-06-14 2010-06-08 Zmed Technologies, Inc. Respiration apparatus
WO2008006090A2 (en) 2006-07-06 2008-01-10 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US20100198103A1 (en) 2007-10-09 2010-08-05 Imthera Medical, Inc. System and method for neural stimulation
EP2230934B8 (de) 2007-12-14 2012-10-24 AeroDesigns, Inc Abgabe von aerosol-sprühbaren nahrungsmittelprodukten
BRPI0920548B8 (pt) 2008-10-09 2021-06-22 Imthera Medical Inc aparelho para controlar posição da língua de um paciente
BR112012010986A2 (pt) 2009-11-10 2016-04-12 Imthera Medical Inc sistema para estimular um nervo hipoglosso para o controle da posição da língua de um paciente
US9844336B2 (en) 2010-08-26 2017-12-19 Ben Gurion University Of The Negev Research And Development Authority Apparatus and method for diagnosing obstructive sleep apnea
US9265649B2 (en) 2010-12-13 2016-02-23 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US20120220531A1 (en) 2011-02-04 2012-08-30 Cincinnati Children's Hospital Medical Center Surfactant protein d for the treatment of disorders associated with lung injury
US10265013B2 (en) 2013-09-06 2019-04-23 Somnology, Inc. System and method for sleep disorder diagnosis and treatment
US10265014B2 (en) 2013-09-06 2019-04-23 Somnology, Inc. System and method for sleep disorder diagnosis and treatment
CN104996566A (zh) * 2015-07-30 2015-10-28 安徽人人福豆业有限公司 一种清肺酒香豆渣发酵乳及其制备方法
CN105053197A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种温中补血豆渣发酵乳及其制备方法
CN105123926A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种疏肝理气豆渣发酵乳及其制备方法
CN105010535A (zh) * 2015-07-30 2015-11-04 安徽人人福豆业有限公司 一种银耳豆渣发酵乳及其制备方法
CN105053191A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种消食木瓜豆渣发酵乳及其制备方法
CN105053196A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种风味草莓豆渣发酵乳及其制备方法
CN105123928A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种润肠豆渣发酵乳及其制备方法
CN105104535A (zh) * 2015-07-30 2015-12-02 安徽人人福豆业有限公司 一种养颜豆渣发酵乳及其制备方法
CN104982527A (zh) * 2015-07-30 2015-10-21 安徽人人福豆业有限公司 一种安神豆渣发酵乳及其制备方法
CN105053194A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种清热通络豆渣发酵乳及其制备方法
CN105053192A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种椰香补肾豆渣发酵乳及其制备方法
CN105053195A (zh) * 2015-07-30 2015-11-18 安徽人人福豆业有限公司 一种去火薄荷味豆渣发酵乳及其制备方法
CN105123927A (zh) * 2015-07-30 2015-12-09 安徽人人福豆业有限公司 一种芦荟健胃豆渣发酵乳及其制备方法
US10786449B2 (en) 2017-07-17 2020-09-29 Northriver Pharm, LLC Nasal composition comprising a mucoadhesive polymer
CN111568853B (zh) * 2020-04-30 2023-07-28 杭州濡湜生物科技有限公司 一种新型肺部智能释药系统

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2520234A1 (fr) * 1982-01-28 1983-07-29 Gros Pierre Composition destinee a la prevention du ronflement
US4826821A (en) * 1985-06-26 1989-05-02 The Regents Of The University Of California Lung surfactant compositions
EP0273916A4 (de) * 1986-05-06 1989-11-30 Childrens Hosp Medical Center Lungenhydrophobes, an ein oberflächenaktives mittel assoziiertes protein von 6000 dalton molekulargewicht sowie multimere davon.
JPS63208524A (ja) * 1987-02-25 1988-08-30 Nippon Oil & Fats Co Ltd 睡眠リズム改善剤
US5238920A (en) * 1989-08-22 1993-08-24 Abbott Laboratories Pulmonary surfactant protein fragments
DE69125750D1 (de) * 1990-05-21 1997-05-28 Abbott Lab Fettsäure-Oberflächenaktives-Lungenprotein Konjate
EP0635028B1 (de) * 1992-04-10 2003-01-22 Abbott Laboratories Fragmente eines oberflächenaktiven lungenproteins
US5569679A (en) * 1994-12-30 1996-10-29 Russell A. Krueger Pharmaceuticals, Inc. Pharmacologic management of snoring
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US5925334A (en) * 1997-08-27 1999-07-20 Rubin; Bruce K. Use of surface active agents to promote mucus clearance

Also Published As

Publication number Publication date
TR199902577T2 (xx) 2000-02-21
IL132133A (en) 2008-12-29
ID29298A (id) 2001-08-16
CN1252727A (zh) 2000-05-10
CO4940399A1 (es) 2000-07-24
US5958902A (en) 1999-09-28
NO994613D0 (no) 1999-09-23
TWI221771B (en) 2004-10-11
WO1998046245A1 (en) 1998-10-22
EP1009411A1 (de) 2000-06-21
DE69830660D1 (de) 2005-07-28
BR9809090A (pt) 2002-12-03
HUP0002645A3 (en) 2002-12-28
US6329352B1 (en) 2001-12-11
US20020099033A1 (en) 2002-07-25
AR012221A1 (es) 2000-09-27
CA2285574C (en) 2007-11-13
EP1009411A4 (de) 2002-10-09
DE69830660T2 (de) 2006-05-04
AU722866B2 (en) 2000-08-10
KR20010006384A (ko) 2001-01-26
JP2001507364A (ja) 2001-06-05
IL132133A0 (en) 2001-03-19
HK1026141A1 (en) 2000-12-08
HUP0002645A2 (hu) 2001-06-28
AU6975598A (en) 1998-11-11
NZ337969A (en) 2001-12-21
CA2285574A1 (en) 1998-10-22
EP1009411B1 (de) 2005-06-22
BG103800A (en) 2000-03-31
SK143199A3 (en) 2001-01-18
KR100381643B1 (ko) 2003-04-26
PL336326A1 (en) 2000-06-19
NO994613L (no) 1999-10-28

Similar Documents

Publication Publication Date Title
ATE298241T1 (de) Behandlung von atemstillstand im schlaf
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE69817446D1 (de) Behandlung von diabetes
DE69836735D1 (de) Behandlung von darmverstopfung
DE69835011D1 (de) Unterschiedliche behandlung von prothesenteilen
ATE301617T1 (de) Behandlung von wasser
DE69500089T2 (de) Behandlung von Geflügel
DE69926385D1 (de) Behandlung von geweben
ATE260332T1 (de) Behandlung von textilien
DE69812681D1 (de) Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia
DE69615105D1 (de) Enzymatische Behandlung von Kakao
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
DE69922631D1 (de) Superkritische behandlung von aktivkohle
DE69841550D1 (de) Behandlung von fibromyalgie und verwandten erkrankungen
DE69810499T2 (de) Behandlung von industriegeweben
DE69932235D1 (de) Behandlung von herzhypertrophie
DE69739850D1 (de) Anti-reflektierende Behandlung von reflektierenden Oberflächen
DE69926485D1 (de) Behandlung von durchblasgasen
ATE346840T1 (de) Aminoalkylphenol-derivate zur behandlung von depression und gedächtnis-funktionsstörung
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
DE69522685D1 (de) Behandlung von blut-plasma
DE69802300D1 (de) Behandlung von schädlichen flüssigkeiten
DE69503929D1 (de) Behandlung von Gasmischungen
DE59803609D1 (de) Behandlung von Kunststoffoberflächen
DE69819503D1 (de) Verwendung von 7-apha-methyl-17-alpha-ethynyl-estrane derivaten zur behandlung von atherosclerose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties